The Role of Fibrocytes in Sickle Cell Lung Disease
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Interstitial lung disease is a frequent complication in sickle cell disease and is characterized by vascular remodeling and interstitial fibrosis. Bone marrow-derived fibrocytes have been shown to contribute to the pathogenesis of other interstitial lung diseases. The goal of this study was to define the contribution of fibrocytes to the pathogenesis of sickle cell lung disease. METHODOLOGY/PRINCIPAL FINDINGS: Fibrocytes were quantified and characterized in subjects with sickle cell disease or healthy controls, and in a model of sickle cell disease, the NY1DD mouse. The role of the chemokine ligand CXCL12 in trafficking of fibrocytes and phenotype of lung disease was examined in the animal model. We found elevated concentration of activated fibrocytes in the peripheral blood of subjects with sickle cell disease, which increased further during vaso-occlusive crises. There was a similar elevations in the numbers and activation phenotype of fibrocytes in the bone marrow, blood, and lungs of the NY1DD mouse, both at baseline and under conditions of hypoxia/re-oxygenation. In both subjects with sickle cell disease and the mouse model, fibrocytes expressed a hierarchy of chemokine receptors, with CXCR4 expressed on most fibrocytes, and CCR2 and CCR7 expressed on a smaller subset of cells. Depletion of the CXCR4 ligand, CXCL12, in the mouse model resulted in a marked reduction of fibrocyte trafficking into the lungs, reduced lung collagen content and improved lung compliance and histology. CONCLUSIONS: These data support the notion that activated fibrocytes play a significant role in the pathogenesis of sickle cell lung disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“studies have found that elevated baseline levels of circulating fibrocytes, a type of mesenchymal, bone marrow–derived cell, are responsible for lung fibrogenesis in SCD mouse models (223).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [223]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546 · cited 12×
“These data are consistent with NY1DD mice and support the notion that disease exacerbations (i.e., VOC) significantly contribute to the development of end organ disease.”
BackgroundInfluentialPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308 · cited 1×
“More recent evidence has implicated a bone marrow-derived circulating mesenchymal progenitor cell, the fibrocyte, in lung fibrosis and has changed the perspective of lung repair [13,14,15].”
BackgroundCirculating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079 · cited 8×
“Fibrocytes are important in mediating pulmonary fibrosis in murine models of lung injury [7,13,19,20,21,22] and are elevated in the blood and lungs of patients with idiopathic pulmonary fibrosis (IPF) [23,24,25].”
BackgroundMethodSelf-citationOutcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients
Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E., & Johnson, C. (2005) · Medicine · doi:10.1097/01.md.0000189089.45003.52 · Cited by 558 · cited 2×
“The two most common complications of SCD, vaso-occlusive pain crises (VOC) and acute chest syndrome (ACS), are the major risk factors for the development of interstitial lung disease (ILD) [2], a risk for morbidity and mortality in patients with SCD [2,3].”
BackgroundResultSickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
Ashley-Koch, A., Yang, Q., & Olney, R. S. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010288 · Cited by 528 · cited 1×
“Sickle cell disease (SCD) is the most common monogenic inherited disorder in African-Americans [1].”
BackgroundCirculating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Moeller, A., Gilpin, S. E., Ask, K., Cox, G., Cook, D., Gauldie, J., Margetts, P. J., Farkas, L., Dobranowski, J., Boylan, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1534oc · Cited by 513 · cited 7×
“This new paradigm for understanding the mechanism of pulmonary fibrosis in SCD implicating bonemarrow-derived fibrocytes is consistent with findings in IPF.”
BackgroundMethodResultSelf-citationPulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470 · cited 2×
“ILD is characterized by parenchymal and vascular remodeling among patients with SCD and has been associated with the development of pulmonary hypertension and, potentially through this mechanism, with increased mortality [2,4].”
BackgroundPhillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 455 · cited 1×
“CXCL12 was neutralized in vivo as previously described [13,26].”
MethodSelf-citationCCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Gilbane, A. J., Denton, C. P., & Holmes, A. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4230 · Cited by 196
“Since then, they have been associated with a broad range of fi brosing disorders, including SSc, sickle cell lung disease, asthma, pulmonary hypertension and atherosclerosis [31-35].”
BackgroundCXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis
Wu, X., Lu, Q., Zhao, H., Lei, W., Liu, Y., Xu, X., Li, J., Yang, Z., Wang, D., Zhang, Y., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101809 · Cited by 119
Weiss, D. J. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201304-090aw · Cited by 62
The role of circulating fibrocytes in inflammation and autoimmunity
Galligan, C. L., & Fish, E. N. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0712365 · Cited by 68
“Interestingly, CXCR4 was reported to predominate over CCR2 and CCR5 for recruitment to murine lungs [27, 33]; however, this may be disease-specific, as CCR5 was critical in a murine lung metastasis model [42].”
BackgroundRuhl, A. P., Sadreameli, S. C., Allen, J. L., Bennett, D. P., Campbell, A., Coates, T. D., Diallo, D. A., Field, J. J., Fiorino, E. K., Gladwin, M. T., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201906-433st · Cited by 61
“Activated neutrophils (75) and fi brocytes (76, 77), proin fl ammatory cytokines (78), exaggerated allergic in fl ammation (71, 79 – 82), increased placental growth factor (83, 84), and increased pulmonary vascular congestion have been implicated in the pathogenesis of airway disease in SCD (59, 85,…”
Self-citationParacrine functions of fibrocytes to promote lung fibrosis
Kleaveland, K. R., Moore, B. B., & Kim, K. K. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.862154 · Cited by 45
Fibrocytes Regulate Wilms Tumor 1–Positive Cell Accumulation in Severe Fibrotic Lung Disease
Sontake, V., Shanmukhappa, S. K., DiPasquale, B. A., Reddy, G. B., Medvedovic, M., Hardie, W. D., White, E. S., & Madala, S. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500963 · Cited by 47
Pulmonary function, CT and echocardiographic abnormalities in sickle cell disease
Lunt, A. C., Desai, S. R., Wells, A. U., Hansell, D. M., Mushemi-Blake, S., Melikian, N., Shah, A. M., Thein, S. L., & Greenough, A. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204809 · Cited by 47
Järve, A., Schira‐Heinen, J., & Müller, H. W. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0068 · Cited by 44
Management of chronic respiratory complications in children and adolescents with sickle cell disease
Arigliani, M., & Gupta, A. (2020) · European Respiratory Review · doi:10.1183/16000617.0054-2020 · Cited by 33
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
Odackal, J., Yu, V., Gomez-Manjerres, D., Field, J. J., Burdick, M. D., & Mehrad, B. (2020) · ERJ Open Research · doi:10.1183/23120541.00481-2020 · Cited by 16
“In mouse models of fibrotic lung disease, fibrocytes rapidly exit the bone marrow to enter the bloodstream after tissue injury and home to the lungs; blocking this migration attenuates lung fibrosis [9-11].”
BackgroundSelf-citationMarinho, C. D. L., Maioli, M. C. P., Amaral, J. L. M., Lopes, A. J., & de Melo, P. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187833 · Cited by 15
Brandalise, S. R., Assis, R., Laranjeira, A. B. A., Yunes, J. A., & de Campos-Lima, P. O. (2017) · Experimental Hematology and Oncology · doi:10.1186/s40164-017-0078-1 · Cited by 14
“However, mobilized fibrocytes might contribute to interstitial lung disease and pulmonary hypertension [53, 55], and a pro-angiogenic environment might accelerate the development of certain complications, such as proliferative”
BackgroundCirculating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease
Mehrad, B., Burdick, M. D., Wandersee, N. J., Shahir, K. S., Zhang, L., Simpson, P. M., Strieter, R. M., & Field, J. J. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017010777 · Cited by 11
“Consistent with the murine models of SCD, these data suggest that circulating fibrocytes are associated with pulmonary dysfunction, which, we propose, is attributed to lung fibrosis.(17) Because fibrocytes are measurable in the circulation, they may represent biomarkers of future lung fibrosis.”
BackgroundMethodResultSelf-citationLin, C. M., Alrbiaan, A., Odackal, J., Zhang, Z., Scindia, Y. M., Sung, S. J., Burdick, M. D., & Mehrad, B. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00176-0 · Cited by 11
Self-citationCirculating fibrocytes as predictors of adverse events in unstable angina
Keeley, E. C., Schutt, R. C., Marinescu, M. A., Burdick, M. D., Strieter, R. M., & Mehrad, B. (2016) · Translational research · doi:10.1016/j.trsl.2016.02.013 · Cited by 9
Self-citationFibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease
Loomis-King, H. A., & Moore, B. B. (2013) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x11309010005 · Cited by 9
“Within the past year fibrocytes have also been implicated in several new murine models of human disease including acute lung injury (ALI) (38),bronchiolitis obliterans (39) and sickle cell lung disease (40).”
BackgroundPeripheral blood fibrocytes: new information to explain the dynamics of Leishmania infection
Silva, R. M. M., dos Santos, C. D. L. P., Diniz, V. Á., de Carvalho, J. J., Guerra, C., & Côrte‐Real, S. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276130247 · Cited by 10
Role of CXCL12/CXCR4-Mediated Circulating Fibrocytes in Pulmonary Fibrosis
Xie, L., & Zhao, L. (2017) · Journal of Biomedicine · doi:10.7150/jbm.18949 · Cited by 5
Karafin, M. S., Dogra, S., Rodeghier, M., Burdick, M. D., Mehrad, B., Rose, C. E., Strieter, R. M., DeBaun, M. R., Strunk, R. C., & Field, J. J. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23248 · Cited by 2
“Fibrocyte levels were not associated with measures of lung function in children with SCA.”
BackgroundResultSelf-citationAlghubayshi, A., Alshabeeb, M. A., Wijesinghe, D. S., AlAwadh, M. A., Alshammari, S., Alrajeh, K., Alkhairi, M., Alaskar, A. S., & Alaskar, A. S. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1671626 · Cited by 1
“This condition is notably common in SCD patients, with 74% of adults in a large prospective cohort study exhibiting a restrictive pattern on pulmonary function tests (Field et al., 2012).”
Firth, A. L., Fernandez, R. A., & Yuan, J. X. ‐. (2013) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4614-9569-7_12
Metadata
- Authors
- Field, J. J., Burdick, M. D., DeBaun, M. R., Strieter, B. A., Liu, L., Mehrad, B., Rose, C. E., Linden, J., & Strieter, R. M.
- Affiliations
- Versiti Blood Center of Wisconsin (US)
- University of Virginia (US)
- Vanderbilt University (US)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Strieter, Robert M.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-19
- Volume
- 7
- Issue
- 3
- Pages
- e33702
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3307761
- OpenAlex
- W2001774986
- Cited by
- 23
- References
- 43
- Citations by year
- 2025: 1 · 2022: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (5f32hl008710-03, UL1TR000448)
- National Heart, Lung, and Blood Institute (R01HL098526, HL073848, HL079937, HL098526, R01HL095704, R01HL079937, HL066027, R01HL098329, HL098329, R01HL066027, R01HL073848, HL08710)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- fibrocytes, interstitial lung disease, CXCL12, CXCR4, chemokine receptors, vaso-occlusive crisis, pulmonary fibrosis, lung collagen, lung compliance
- MeSH terms
- Adult, Anemia, Sickle Cell, Animals, Cell Movement, Collagen, Female, Humans, Male, Middle Aged, Pulmonary Fibrosis, Lung Diseases, Interstitial, Receptors, Chemokine, Mice, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.